跳至主要内容
临床试验/NCT00245440
NCT00245440终止4 期

Influence of Oral Telithromycin vs. Azithromycin on the Endogenous Microflora in Adults With Acute Sinusitis

CPL Associates1 个研究点 分布在 1 个国家目标入组 192 人开始时间: 2005年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
192
试验地点
1
主要终点
Bacterial resistance or selection

研究概览

简要总结

The purpose of this study is to measure the speed of microbial eradication due to azithromycin or telithromycin in acute maxillary sinusitis (AMS).

详细描述

The objectives of this study are:

  • To assess the impact of therapy with telithromycin vs. azithromycin on the oral microflora in patients with acute maxillary sinusitis at day 42 and to compare the duration of colonization with resistant oropharyngeal flora in patients treated with azithromycin vs. telithromycin.
  • To also compare the two treatment groups for rate of reinfection within 6 weeks and the susceptibility pattern of the organisms appearing during the reinfection and differences in development of resistance and the associated changes in symptom responses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients, either males or non-pregnant females, aged 18 to 75 years of age with clinical findings of acute maxillary sinusitis (AMS), who are amenable to serial sampling of the nasopharynx and oropharynx.
  • Patients are required to have specimens of nasal and nasopharyngeal drainage collected for microbiological documentation within 24 hours prior to enrollment. All patients must produce sinus fluid drainage.
  • All patients will produce nasal or nasopharyngeal discharge sufficient for baseline culture.
  • Female patients of child bearing potential must agree to use an accepted method of contraception (i.e., oral or implanted contraceptive with a barrier method, spermicide and barrier methods, or intrauterine device [IUD]). The patient must agree to continue with the same method throughout the study.

排除标准

  • Patients with a history of recurrent sinusitis defined as more than three episodes of sinusitis which required antibiotic therapy in the preceding 12 months
  • Patients with a history of chronic sinusitis defined as symptoms lasting greater than 28 days
  • Patients with nosocomial acquired sinusitis (e.g., hospitalization or non-ambulatory institutional confinement including nursing homes within 2 weeks)
  • Patients with a need for immediate surgery for maxillary sinusitis or previous sinus surgery within the past 6 months or sinus lavage within the past 7 days
  • Patients who are long-term (> 4 weeks) users of nasal decongestants (e.g. oxymetazoline 0.05%)
  • Patients with a known or suspected hypersensitivity to, or a known or suspected serious adverse reaction to, any macrolide antibiotic
  • Impaired hepatic or renal function (creatinine clearance [CCL] <20 ml/min)
  • Severe respiratory tract infections requiring hospitalization and parenteral antibiotic therapy.
  • Requirement for a concomitant antimicrobial agent other than topical, antiviral or antifungal agents.
  • Treatment with any macrolide, azalide, or ketolide antimicrobial within the 30 days prior to entry into the study.

研究组 & 干预措施

1

Active Comparator

Subjects assigned Azithromycin

干预措施: Azithromycin (Drug)

2

Active Comparator

Subjects assigned Telithromycin

干预措施: Telithromycin (Drug)

结局指标

主要结局

Bacterial resistance or selection

时间窗: 42 days

次要结局

  • Bacteriologic outcome(42 days)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验